Infliximab in serpiginous choroiditis.
Pascal
P
Seve
Emeline
E
Mennesson
Jean-Daniel
JD
Grange
Christiane
C
Broussolle
Laurent
L
Kodjikian
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002833:Choroiditis / Q000175:diagnosis / Q000188:drug therapy*; D004396:Coloring Agents; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D004396:Coloring Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D007208:Indocyanine Green